Electrical tinnitus suppression: A double-blind crossover study

Robert A Dobie, K. E. Hoberg, T. S. Rees

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

A wearable device for transcutaneous electrical tinnitus suppression (ETS) has recently been reported to be effective for relief of tinnitus. Twenty patients with sensorineural hearing loss and tinnitus participated in a double-blind crossover study. Both active devices and internally disconnected placebo devices, supplied by the manufacturer, were used. Reduction in severity of tinnitus was reported by 2 of 20 patients (10%) with the active device and by 4 of 20 (20%) with the placebo device. Fifteen of 20 (75%) had no relief with either device. Those who preferred the placebo device, however, reported only minimal relief, while one of the 2 who preferred the active device stated it had reduced tinnitus severity by 70% to 80%. This patient was recalled for a series of one-hour test sessions, during which either an active or placebo device was used, according to a random schedule. On each of 4 on trials, the score for severity of tinnitus for each ear decreased by at least 50% (median = 70%), while in 3 off trials, the severity of tinnitus was unchanged or decreased by up to 30% (median = 16%). We conclude that the Theraband headset is effective for a small proportion of patients with sensorineural hearing loss and tinnitus.

Original languageEnglish (US)
Pages (from-to)319-323
Number of pages5
JournalOtolaryngology - Head and Neck Surgery
Volume95
Issue number3 I
StatePublished - 1986
Externally publishedYes

Fingerprint

Tinnitus
Double-Blind Method
Cross-Over Studies
Equipment and Supplies
Placebos
Sensorineural Hearing Loss
Ear
Appointments and Schedules

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Dobie, R. A., Hoberg, K. E., & Rees, T. S. (1986). Electrical tinnitus suppression: A double-blind crossover study. Otolaryngology - Head and Neck Surgery, 95(3 I), 319-323.

Electrical tinnitus suppression : A double-blind crossover study. / Dobie, Robert A; Hoberg, K. E.; Rees, T. S.

In: Otolaryngology - Head and Neck Surgery, Vol. 95, No. 3 I, 1986, p. 319-323.

Research output: Contribution to journalArticle

Dobie, RA, Hoberg, KE & Rees, TS 1986, 'Electrical tinnitus suppression: A double-blind crossover study', Otolaryngology - Head and Neck Surgery, vol. 95, no. 3 I, pp. 319-323.
Dobie, Robert A ; Hoberg, K. E. ; Rees, T. S. / Electrical tinnitus suppression : A double-blind crossover study. In: Otolaryngology - Head and Neck Surgery. 1986 ; Vol. 95, No. 3 I. pp. 319-323.
@article{9fdafc4343d74960a421b77c506b3e5a,
title = "Electrical tinnitus suppression: A double-blind crossover study",
abstract = "A wearable device for transcutaneous electrical tinnitus suppression (ETS) has recently been reported to be effective for relief of tinnitus. Twenty patients with sensorineural hearing loss and tinnitus participated in a double-blind crossover study. Both active devices and internally disconnected placebo devices, supplied by the manufacturer, were used. Reduction in severity of tinnitus was reported by 2 of 20 patients (10{\%}) with the active device and by 4 of 20 (20{\%}) with the placebo device. Fifteen of 20 (75{\%}) had no relief with either device. Those who preferred the placebo device, however, reported only minimal relief, while one of the 2 who preferred the active device stated it had reduced tinnitus severity by 70{\%} to 80{\%}. This patient was recalled for a series of one-hour test sessions, during which either an active or placebo device was used, according to a random schedule. On each of 4 on trials, the score for severity of tinnitus for each ear decreased by at least 50{\%} (median = 70{\%}), while in 3 off trials, the severity of tinnitus was unchanged or decreased by up to 30{\%} (median = 16{\%}). We conclude that the Theraband headset is effective for a small proportion of patients with sensorineural hearing loss and tinnitus.",
author = "Dobie, {Robert A} and Hoberg, {K. E.} and Rees, {T. S.}",
year = "1986",
language = "English (US)",
volume = "95",
pages = "319--323",
journal = "Otolaryngology - Head and Neck Surgery (United States)",
issn = "0194-5998",
publisher = "Mosby Inc.",
number = "3 I",

}

TY - JOUR

T1 - Electrical tinnitus suppression

T2 - A double-blind crossover study

AU - Dobie, Robert A

AU - Hoberg, K. E.

AU - Rees, T. S.

PY - 1986

Y1 - 1986

N2 - A wearable device for transcutaneous electrical tinnitus suppression (ETS) has recently been reported to be effective for relief of tinnitus. Twenty patients with sensorineural hearing loss and tinnitus participated in a double-blind crossover study. Both active devices and internally disconnected placebo devices, supplied by the manufacturer, were used. Reduction in severity of tinnitus was reported by 2 of 20 patients (10%) with the active device and by 4 of 20 (20%) with the placebo device. Fifteen of 20 (75%) had no relief with either device. Those who preferred the placebo device, however, reported only minimal relief, while one of the 2 who preferred the active device stated it had reduced tinnitus severity by 70% to 80%. This patient was recalled for a series of one-hour test sessions, during which either an active or placebo device was used, according to a random schedule. On each of 4 on trials, the score for severity of tinnitus for each ear decreased by at least 50% (median = 70%), while in 3 off trials, the severity of tinnitus was unchanged or decreased by up to 30% (median = 16%). We conclude that the Theraband headset is effective for a small proportion of patients with sensorineural hearing loss and tinnitus.

AB - A wearable device for transcutaneous electrical tinnitus suppression (ETS) has recently been reported to be effective for relief of tinnitus. Twenty patients with sensorineural hearing loss and tinnitus participated in a double-blind crossover study. Both active devices and internally disconnected placebo devices, supplied by the manufacturer, were used. Reduction in severity of tinnitus was reported by 2 of 20 patients (10%) with the active device and by 4 of 20 (20%) with the placebo device. Fifteen of 20 (75%) had no relief with either device. Those who preferred the placebo device, however, reported only minimal relief, while one of the 2 who preferred the active device stated it had reduced tinnitus severity by 70% to 80%. This patient was recalled for a series of one-hour test sessions, during which either an active or placebo device was used, according to a random schedule. On each of 4 on trials, the score for severity of tinnitus for each ear decreased by at least 50% (median = 70%), while in 3 off trials, the severity of tinnitus was unchanged or decreased by up to 30% (median = 16%). We conclude that the Theraband headset is effective for a small proportion of patients with sensorineural hearing loss and tinnitus.

UR - http://www.scopus.com/inward/record.url?scp=0023032213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023032213&partnerID=8YFLogxK

M3 - Article

C2 - 3108780

AN - SCOPUS:0023032213

VL - 95

SP - 319

EP - 323

JO - Otolaryngology - Head and Neck Surgery (United States)

JF - Otolaryngology - Head and Neck Surgery (United States)

SN - 0194-5998

IS - 3 I

ER -